article thumbnail

A New Dimension in New Drug Molecules Research with Nanome’s VR technology [Interview]

Pharma Mirror

The COVID-19 pandemic challenged researchers to discover life-saving treatments at an unprecedented pace. While these researchers rose to the occasion by discovering drugs faster than ever before, variants continue to challenge the world in addressing COVID-19.

Research 264
article thumbnail

Rankings: Research and Development

Pharmaceutical Technology

What is Research and Development (R&D)? This category includes organisations that have demonstrated a commitment to the research and development of new products and/or new processes. This category highlights companies that have advanced drug development research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Editas to cut jobs, narrow research focus in restructuring

Bio Pharma Dive

The CRISPR-focused biotech will lay off 20% of its workforce, stop development of two eye disease treatments and end some early-stage cell therapy research

Research 297
article thumbnail

Clinical trial researchers are burned out too. Automated data capture is helping.

Bio Pharma Dive

Manual data transcription increases clinical research coordinator burnout. There is a better way

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Biotech CFOs eye research cuts, partnerships amid sector retrenchment: report

Bio Pharma Dive

The report, a yearly poll of 100 financing executives by accounting and consulting firm BDO, revealed the many levers young drugmakers are pulling to conserve cash

Research 340
article thumbnail

LCRF, Daiichi Sankyo and AstraZeneca enter research collaboration

Pharmaceutical Technology

The Lung Cancer Research Foundation (LCRF) has announced a new research partnership with Daiichi Sankyo and AstraZeneca. It is an exciting and promising area in lung cancer research.”

Antibody 246
article thumbnail

Boost agility and speed in your drug development research

Bio Pharma Dive

How flexible API access to integrated 'omics data helps boost agility and speed in drug research

article thumbnail

PureTech, tweaking research, trims a ‘small number’ of positions

Bio Pharma Dive

The biotech company creator is deprioritizing work on a drug delivery technology called Orasome after what it described as a “key go/no go” experiment

article thumbnail

Biotechs reveal layoffs, research revamps in third quarter earnings

Bio Pharma Dive

Tricida, Harpoon, Freeline and three other small drug developers have this week announced plans to cut staff or to reprioritize their drug development

Research 346
article thumbnail

Breakthroughs in Clinical Research

Riverside Clinical Research

Clinical research enables doctors and researchers to develop a better understanding of diseases. Although his successful research results were dismissed for decades, Lind actually discovered the cure for scurvy. Velocity Clinical Research is conveniently located at 1410 S.

article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

Who Is Velocity Clinical Research?

Riverside Clinical Research

A wholly-owned clinical trial site model, Velocity Clinical Research provides an integrated approach to ensure expedited study set-up, accelerated patient enrollment, excellent patient care and comfort, reliable results and superior data delivery. The post Who Is Velocity Clinical Research?

article thumbnail

Feinstein Institutes researchers discover new protein for sepsis treatment

Pharmaceutical Technology

Researchers at the Feinstein Institutes for Medical Research have discovered a new protein that can be a potential therapeutic target for lethal sepsis. Despite decades of research, there remains a lack of treatment.

Protein 263
article thumbnail

Utilizing Integrated Technology Solutions to Address Key Cancer Research Challenges

Forte Research Systems®

Integrated research solutions are beneficial to cancer centers in more ways than one — institutions can leverage technology, services, and IRB/IBC to streamline research. Clinical Research Technologies Efficient Clinical Trials Site Management

article thumbnail

More bad research on pharma websites

World of DTC Marketing

The post More bad research on pharma websites appeared first on World of DTC Marketing.com. As I See It Bad Research

Marketing 143
article thumbnail

How are digital biomarkers reshaping Parkinson’s disease research?

Bio Pharma Dive

Your Parkinson’s disease trials need better data. Hear how digital biomarkers change the game

Trials 246
article thumbnail

Predictive Oncology partners with Cancer Research Horizons

Pharmaceutical Technology

Predictive Oncology and Cancer Research Horizons, a part of Cancer Research UK (CRUK), has collaborated to drive cancer drug development using the former’s PEDAL platform.

Drugs 130
article thumbnail

Odyssey recruits news investors to fund precision drug research

Bio Pharma Dive

A $168 million Series B round brings Odyssey’s total funding to date near $400 million, helping the startup support a growing pipeline of cancer and immune disease drug candidates

Research 296
article thumbnail

UTSA researchers to develop compounds for GBM tumours

Pharmaceutical Technology

A researchers’ team from the University of Texas at San Antonio’s (UTSA) Department of Chemistry and its partners are developing compounds to treat Glioblastoma multiforme (GBM) tumours. The National Cancer Institute (NCI) has recently awarded a $3m grant to the researchers’ team.

article thumbnail

Post Marketing Research

Cloudbyz

Premarketing drug studies vs Post- Marketing research. Post-marketing research is a generic term used to describe all activities after drug approval by the regulatory agencies, such as the Food and Drug Administration (FDA). Post market research for monitoring drug safety.

article thumbnail

J&J opens new research hub near San Francisco

Bio Pharma Dive

The roughly 200,000-square-foot facility will house about 400 employees and more than double the size of the drugmaker’s presence in San Francisco

Research 283
article thumbnail

Researchers of the Year: The RECOVERY team

Bio Pharma Dive

The U.K.'s 's RECOVERY trial proved a cheap steroid could keep COVID-19 patients from dying, and showed two other widely considered drugs didn't work — crucial findings in a sprawling and sometimes messy global hunt for coronavirus treatments

Research 332
article thumbnail

Pfizer expands into gene editing with Beam research deal

Bio Pharma Dive

Pfizer's work with mRNA vaccines led it explore other applications of the technology, resulting in a multi-year partnership with the high-profile biotech Beam Therapeutics on gene editing treatments for rare diseases

article thumbnail

iOnctura reveals roginolisib research results

Pharma Times

Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients

Research 111
article thumbnail

6 research and development life sciences predictions for 2023

Pharma Phorum

The post 6 research and development life sciences predictions for 2023 appeared first on. R&D Views & Analysis Views and analysis 2023 trends access data patient choice regulatory research and development safety technology

article thumbnail

AI-powered Innovations in Clinical Research

Riverside Clinical Research

We are transforming the world of clinical research through artificial intelligence-powered technology…reducing clinical trial times, increasing clinical trial productivity and success rates, and improving costs; all of which result in greater advancements in medicine.

article thumbnail

UK atrial fibrillation research incorporates Brainomix

Pharma Times

Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients

Research 121
article thumbnail

Novartis’ Bradner steps down as research head amid company shake-up

Bio Pharma Dive

A well-known physician-scientist who joined Novartis from Harvard, Jay Bradner spent over six years steering the company’s research hub. He will be replaced by Merck executive Fiona Marshall

Scientist 280
article thumbnail

Takeda reels in a cell therapy research partner with 'build-to-buy' deal

Bio Pharma Dive

The Japanese drugmaker is acquiring GammaDelta Therapeutics, a partner since 2017, and its research on allogeneic cell therapy for cancer

Research 326
article thumbnail

Icon to buy contract researcher PRA Health for $12B

Bio Pharma Dive

The cash-and-stock deal gives PRA shareholders roughly one-third ownership of the new company, which will be one of the larger providers of contract research support

Research 285
article thumbnail

Pfizer lures research chief from Roche, prompting high-level reshuffle

Bio Pharma Dive

William Pao led discovery and early development at the Swiss drugmaker, and will now head Pfizer's global efforts to launch new products

Research 324
article thumbnail

Sickle cell pipeline narrows as gene therapy developers rethink research plans

Bio Pharma Dive

Graphite Bio and Sangamo are stopping work on their respective sickle cell gene therapies, while Intellia revealed partner Novartis ended development of its genetic treatment for the blood disease

article thumbnail

Sanofi and Queensland collaborate to build $190m research facility

Pharmaceutical Technology

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. The facility will leverage the infrastructure and labs of both universities and the Translational Research Institute (TRI). .

article thumbnail

Fate, two other cell therapy biotechs lay off staff, restructure research

Bio Pharma Dive

The cuts at Fate, Century Therapeutics and TCR2 Therapeutics signal a longer road in the companies’ plans to develop next-generation cell therapies for cancer

article thumbnail

Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin

Pharma Mirror

The DREAM study is an observational, non-pharmacologic and non-interventional clinical study initiated by certain researchers participating in the. The post Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin appeared first on Pharma Mirror Magazine.

Research 130
article thumbnail

Blockchain: Ready to revolutionise medicinal cannabis research?

Pharma Phorum

As cannabis legalisation spreads, so too does medical research into all the benefits we can derive from THC, CBD, and the various terpenes to be found in the cannabis flower. In research as in cryptocurrency, even the slightest inconsistency could be disastrous.

Medicine 130
article thumbnail

Roles and Responsibilities of a Clinical Research Coordinator

Forte Research Systems®

Clinical Research Coordinators are tasked with many responsibilities throughout the day. Learn more about how to balance each role and responsibility effectively. Site Management Study Coordination

article thumbnail

Kids and Research

My Local Study

She knew I had a research background. Read more Kids and Research. The post Kids and Research appeared first on MyLocalStudy.com. Clinical Trials Kids in Research blog clinical research pediatric research

article thumbnail

OPDP Outlines New Research

Eye on FDA

FDA published notice recently that the Office of Prescription Drug Promotion (OPDP) was proposing some new research related to the promotion of medicines by pharmaceutical companies. The research was new (kind of) but the direction was more of the same old focus – direct-to-consumer advertising (DTC). First, just a note on why the research is of importance at all. FDA Policy Research #DTC #OPDP #pharma

article thumbnail

Lilly deepens research ties in China with biotech deal

Bio Pharma Dive

The collaboration with Regor Therapeutics is another example of large pharma companies' interest in partnering with emerging biotechs from China

article thumbnail

Nimbus partners with Eli Lilly on metabolic disease research

Bio Pharma Dive

While Nimbus has drawn attention for its work on a TYK2 inhibitor, Lilly is interested in the company’s research around an enzyme called AMPK that’s seen as a useful, but hard-to-reach drug target

Drugs 166
article thumbnail

Orchard turns to layoffs in cutting gene therapy research

Bio Pharma Dive

The biotech company plans to reduce its workforce by 30%, or by about 65 employees, in the latest example of a gene therapy developer restructuring